Announcements Trials
Browse Landscape

Status

Recruiting 6Completed 3Terminated 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 10Observational 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Breast Neoplasms 1388Neoplasms 1168Colorectal Neoplasms 626Lung Neoplasms 562Prostatic Neoplasms 538Carcinoma, Non-Small-Cell Lung 444Carcinoma, Hepatocellular 296Stomach Neoplasms 272Pancreatic Neoplasms 270Colonic Neoplasms 264Ovarian Neoplasms 231Head and Neck Neoplasms 228Rectal Neoplasms 221Melanoma 216Multiple Myeloma 204Uterine Cervical Neoplasms 198Lymphoma 195Leukemia 193Precursor Cell Lymphoblastic Leukemia-Lymphoma 191Neoplasm Metastasis 178Carcinoma, Renal Cell 177Brain Neoplasms 174Esophageal Neoplasms 173Leukemia, Myeloid, Acute 158Urinary Bladder Neoplasms 138Recurrence 123Polycystic Ovary Syndrome 122Liver Neoplasms 119Hematologic Neoplasms 117Endometrial Neoplasms 107

Interventions

radium Ra 223 dichloride 1Radionuclide Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Observational × Metastatic Castration-resistant Prostate Cancer × Clear all
NCT02141438 2025-10-16

REASSURE

Bayer

Completed
1,472 enrolled 18 charts
Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT04000776 2023-08-28

3TMPO (Triple-Tracer Strategy Against Metastatic Prostate Cancer

Université de Sherbrooke

Completed
100 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT04268628 2022-01-03

EXPLORE

Janssen-Cilag Farmaceutica Ltda.

Completed
42 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡